MACA-Prim
MACA-Prim, licence 80040448: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- MACA-Prim Peru Ginseng
- Licence holder
- Provita Nutrition and Health Inc.
- NPN or DIN-HM
- 80040448
- Status
- Active licence
- Licence date
- 28 February 2013
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Traditionnelle
If this product were sold in France
- Conditions légales
Lepidium meyenii Walp.: L'absence d'alcaloïdes doit être démontrée par des rapports d'analyse.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Lepidium meyenii Source : Racine Extract : Extract Type TBA Extraction ratio : 5.0:1.0 Dry plant equivalent : 750.0 mg | 150.0 mg | Not calculated |
| Lepidium meyenii Source : Racine | Not specified | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Gélatine, Cellulose microcristalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1.0 Capsule | 2.0 Jour(s) |
Uses authorised in Canada
Helps to support healthy mood balance during menopause.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner if you are pregnant of breast feeding, if you are taking antidepressants or blood thinners, if you have high blood pressure or if you suffer from any psychological disorder and/or condition such as frequent anxiety or depression.
Source
Official Health Canada record, licence 80040448
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.